Nirvana Life Sciences Inc.
NIRV
CNSX
| 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.00% | 35.71% | -82.61% | -94.20% | -93.65% |
| Total Receivables | -11.68% | -11.03% | -0.72% | -23.60% | -21.26% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -15.29% | -6.00% | -61.48% | -68.54% | -77.57% |
|
|
|||||
| Total Current Assets | -15.29% | -6.00% | -61.48% | -68.54% | -77.57% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -15.29% | -6.00% | -91.09% | 215.73% | -77.57% |
|
|
|||||
| Total Accounts Payable | 6.24% | 39.86% | -32.23% | 7.75% | 24.17% |
| Total Accrued Expenses | -75.37% | 21.20% | 22.95% | 38.90% | 36.75% |
| Short-term Debt | 211.52% | 246.12% | 279.66% | 217.95% | 298.36% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | 0.00% | -- | 0.00% | -3.85% |
| Total Other Current Liabilities | -- | 0.00% | -- | 0.00% | -3.85% |
| Total Current Liabilities | -55.07% | 29.49% | 19.42% | 38.01% | 36.74% |
|
|
|||||
| Total Current Liabilities | -55.07% | 29.49% | 19.42% | 38.01% | 36.74% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 211.52% | 246.12% | 279.66% | 217.95% | 298.36% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -100.00% | -- | -- | -- | -- |
| Total Liabilities | -55.15% | 29.49% | 21.78% | 57.04% | 36.98% |
|
|
|||||
| Common Stock & APIC | 13.67% | -0.54% | -7.56% | -0.33% | -4.77% |
| Retained Earnings | -3.39% | -3.69% | 1.48% | -5.21% | -1.89% |
| Treasury Stock & Other | 2.49% | 2.16% | -2.74% | 13.51% | 23.24% |
| Total Common Equity | 56.11% | -30.28% | -51.22% | -45.63% | -51.18% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 56.11% | -30.28% | -51.22% | -45.63% | -51.18% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 2.70% | 0.00% | -14.29% | -25.81% | -23.33% |
| Total Equity | 55.88% | -30.14% | -51.02% | -45.53% | -51.03% |
|
|
|||||